Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Gastrointestinal 2Tumor-Agnostic 1Other hematologic neoplasm 1Breast 1

Conditions

Lymphoma 2Lymphoma, Large B-Cell, Diffuse 1Gastrointestinal Neoplasms 1

Interventions

Rituximab 702Cyclophosphamide 645Vincristine 353Doxorubicin 309Etoposide 305Cytarabine 271Filgrastim 250Prednisone 249Methotrexate 241fludarabine phosphate 231Dexamethasone 209fludarabine 184Peripheral Blood Stem Cell Transplantation 166Radiotherapy 161Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 111Mycophenolic Acid 108Whole-Body Irradiation 107Tacrolimus 96Cyclosporine 87Gemcitabine 82Ifosfamide 80Calcium Dobesilate 80Alemtuzumab 80Leucovorin 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Weights and Measures × Lymphoid × Clear all
NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

H. Lee Moffitt Cancer Center and Research Institute

Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03530969 2024-02-20

Geriatric Communication Skills Training Program for Oncology Clinicians

Memorial Sloan Kettering Cancer Center

Phase NA Completed
88 enrolled
GastrointestinalLymphoid

Gastrointestinal Neoplasms, Lymphoma

NCT03260855 2023-08-23

PResEnCE

University Hospital, Toulouse

Phase NA Completed
200 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡